
Triple hormone-pathway research compound. Clinical-trial results are promising; safety and effectiveness are still being evaluated.
Reta Max 50mg — retatrutide, a triple hormone receptor agonist still being studied, supplied as a 50mg/3mL pen.
Reta Max is labelled as containing retatrutide, a triple hormone receptor agonist that targets three pathways: GLP-1 (involved in appetite regulation and blood-glucose control), GIP (involved in insulin secretion and metabolic regulation) and glucagon (involved in energy metabolism). Retatrutide is being studied for weight management and metabolic conditions. Clinical-trial results are promising, but its safety and effectiveness are still being evaluated. Listed strength: 50mg in 3ml.
Retatrutide acts on three receptor pathways: GLP-1, involved in appetite regulation and blood-glucose control; GIP, involved in insulin secretion and metabolic regulation; and glucagon, involved in energy metabolism.
Reported side effects in clinical trials include nausea, diarrhoea, vomiting and constipation. Long-term safety is still being investigated. Do not combine it with other appetite-suppressant or glucose-lowering medications without medical supervision. Anyone considering weight-management treatment should discuss approved alternatives with a qualified healthcare professional.
It should not be considered a routine weight-loss option for healthy, lean individuals or used without appropriate medical oversight.
Product label: 50mg / 3mL. Frequency shown on the packaging: weekly. Click range shown on the packaging: 15–30 clicks weekly.
Clinical trials are investigating retatrutide in adults with obesity or overweight accompanied by weight-related health conditions, including type 2 diabetes. It should not be considered a routine weight-loss option for healthy, lean individuals or used without appropriate medical oversight. Discuss approved weight-management alternatives with a qualified healthcare professional before considering this product.
Listed format: pre-filled multidose pen. The packaging shows a weekly frequency and a 15–30 click range; confirm the intended route, compatible device and manufacturer instructions. Do not infer click counts beyond what the packaging states; use sterile single-use needles only under qualified medical guidance where appropriate.
Follow the manufacturer’s label for the exact formulation, temperature range and expiry before and after opening or mixing. Request these instructions before ordering if missing. Do not assume a universal 30-day shelf life; keep away from heat and light and out of children’s reach. Ask for advice after any temperature excursion.
Clinical-trial results are promising, but safety and effectiveness are still being evaluated.
Do not combine it with other appetite-suppressant or glucose-lowering medications without medical supervision. Ask a qualified clinician to review ingredients, medicines, medical history and monitoring requirements.
Contact Peak Protocol for the current batch’s identity, strength, purity and, where relevant, sterility/endotoxin documentation. No universal purity percentage or accreditation is assumed.
Contact us within 2 days with photo or video evidence. No product refunds: approved returns are for store credit only after inspection. Return courier costs are paid by the client. See the full returns policy.